TKNO as of Nov 2 · 11:12 ET

TKNONasdaqIn Vitro & In Vivo Diagnostic Substances

Alpha Teknova, Inc. · Brief

Next report

3 days

Nov 5 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±23.4%implied · straddle

5.649.08

spot 7.36exp Nov 20ATM strike 7.5ATM straddle 2.03IV 143%

Oct 30 close

Expected move

Inputs

Implied vs realized

8 reportsHistory

0 of 4≥ implied

avg implied: ±53.0%
avg realized: ±10.4%

Nov 7 '24—▲+3.92%—

Mar 4 '25—▼−1.16%—

May 8 '25—▲+9.26%—

Aug 7 '25—▼−2.53%—

Q3 FY25±56.5%▼−2.08%×0.04

Q1 FY26±83.1%▲+13.16%×0.16

May 6 '26±51.5%▲+9.89%×0.19

Q2 FY26±20.7%▲+16.40%×0.79

quarterimplied−85%0+85%realized×

Q2 FY26±20.7%▲+16.40%×0.79

May '26±51.5%▲+9.89%×0.19

Q1 FY26±83.1%▲+13.16%×0.16

Q3 FY25±56.5%▼−2.08%×0.04

Aug '25—▼−2.53%—

May '25—▲+9.26%—

2 older reports

Mar '25—▼−1.16%—

Nov '24—▲+3.92%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

79managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+36.38%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

4 of 4recent reports where the move came in under the options-implied rangeEarnings history

9managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TKNO report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 23impliedImplied move: ±31.3% into Nov 5 earnings (Oct 23 close).Source

Oct 218-KMaterial agreement: underwriting agreement with TD Securities (USA) LLC and William Blair & Company, L.L.C.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.